All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

65

Reset

65 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • GiredestrantRO7197597, GDC-9545Phase 316 trials

    Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

  • ZanzalintinibXL092Phase 311 trials

    Exelixis · Colorectal Cancer, Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma

  • AtirmociclibPF-07220060Phase 39 trials

    Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer

  • LHRH AgonistPhase 36 trials

    Roche (Genentech) · Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Early Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

  • LUM-201Phase 36 trials

    Lumos Pharma · Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity & Overweight

  • MHB018APhase 36 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Thyroid Eye Disease (TED), Thyroid Eye Disease, TED, Thyroid Associated Ophthalmopathies

  • CRN04894AtumelnantPhase 35 trials

    Crinetics Pharmaceuticals Inc. · Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia, Cushing Syndrome

  • VRDN-003ZL-1109Phase 35 trials

    Viridian Therapeutics, Inc. · Thyroid Eye Disease, Thyroid Eye Disease (TED)

  • InpegsomatropinPhase 34 trials

    Xiamen Amoytop Biotech Co., Ltd. · Turner Syndrome, Idiopathic Short Stature, Adult Growth Hormone Deficiency

  • ZN-c3azenosertibPhase 34 trials

    K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Ovarian Cancer, High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer, Uterine Serous Carcinoma

  • AL2846Phase 33 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Thyroid Cancer, Differentiated Thyroid Cancer, Advanced Lung Cancer

  • BatoclimabIMVT-1401Phase 33 trials

    Immunovant Sciences GmbH · Thyroid Eye Disease, Graves Disease

  • CAM2029octreotide depotPhase 33 trials

    Camurus AB · Polycystic Liver Disease, Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly

  • EncaleretCLTX-305Phase 33 trials

    Calcilytix Therapeutics, Inc., a BridgeBio company · Autosomal Dominant Hypocalcemia Type 1 (ADH1), Autosomal Dominant Hypocalcemia (ADH), Hypoparathyroidism

  • IBI311Phase 33 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Thyroid Eye Disease, Thyroid Eye Disease, TED

  • Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials

    Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate

  • MT1013Phase 33 trials

    Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis, Secondary Hyperparathyroidism, Chronic Kidney Disease

  • PacibekitugTOUR006, PAC001Phase 33 trials

    Tourmaline Bio, Inc., a Novartis Company · Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases

  • PLS240upacicalcetPhase 33 trials

    Pathalys Pharma · Secondary Hyperparathyroidism, Chronic Kidney Disease (CKD), End-stage Kidney Disease (ESKD)

  • SYHX2008Phase 33 trials

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Diagnosed With Acromegaly, Currently in the Active Stage of the Disease, Gastrointestinal Neuroendocrine Pancreatic Tumor, Acromegaly

  • CanvuparatideMBX 2109Phase 32 trials

    MBX Biosciences · Hypoparathyroidism

  • hMGPhase 32 trials

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Infertility, Infertility (IVF Patients)

  • KHN939Phase 32 trials

    Beijing Kanghong Biological Medicine Co., Ltd. · Thyroid Eye Disease

  • KLH-2109Phase 32 trials

    JW Pharmaceutical · Menorrhagia, Uterine Fibroids, Endometriosis

  • linsitinibPhase 32 trials

    Sling Therapeutics, Inc. · Graves Orbitopathy, Thyroid Eye Disease, TED, Thyroid Eye Disease

  • Pathalys Pharma · Secondary Hyperparathyroidism, End-stage Kidney Disease (ESKD), End Stage Kidney Disease

  • RYZ101Phase 32 trials

    RayzeBio, Inc. · Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer

  • SHR6508Phase 32 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Secondary Hyperparathyroidism, Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

  • Debio 4126Phase 31 trial

    Debiopharm International SA · Acromegaly

  • FE 999049Rekovelle, Follitropin DeltaPhase 31 trial

    Ferring Pharmaceuticals · Infertility, Female

  • GB06Phase 31 trial

    Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric

  • HMI-115Phase 31 trial

    Hope Medicine (Nanjing) Co., Ltd · Endometriosis

  • MR-100A-01Transdermal contraceptive delivery systemPhase 31 trial

    Mylan Technologies Inc. · Contraception

  • QL1206Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Postmenopausal Women With Osteoporosis at High Risk of Fracture

  • QLG2128Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Postmenopausal Women With Osteoporosis

  • TUB-040Phase 24 trials

    Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer

  • GenSci048Phase 23 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)

  • GV20-0251Phase 23 trials

    GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum

  • Lu AG13909AsedebartPhase 23 trials

    H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital

  • SPI-62clofutriben, ASP3662Phase 23 trials

    Sparrow Pharmaceuticals · Cortisol Excess, Type 2 Diabetes, Polymyalgia Rheumatica

  • ST-1898Phase 23 trials

    Beijing Scitech-Mq Pharmaceuticals Limited · Advanced Renal Cell Carcinoma, Differentiated Thyroid Carcinoma, Unresectable or Metastatic Melanoma

  • Teverelix DPPhase 23 trials

    Antev Ltd. · Acute Urinary Retention, Benign Prostate Hypertrophy(BPH), Endometriosis Pelvic

  • AMG 732Phase 22 trials

    Amgen · Thyroid Eye Disease

  • endoxifenPhase 22 trials

    Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer

  • GenSci134Phase 22 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Pediatric Growth Hormone Deficiency, Idiopathic Short Stature

  • LASN01Phase 22 trials

    Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy

  • ABCL635Phase 21 trial

    AbCellera Biologics Inc. · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers

  • AGA2118Phase 21 trial

    Angitia Biopharmaceuticals · Postmenopausal Osteoporosis

  • CTAP101Phase 21 trial

    OPKO Health, Inc. · CKD Stage 3, CKD Stage 4, Secondary Hyperparathyroidism

  • EXT608Phase 21 trial

    Extend Biosciences Inc. · Hypoparathyroidism

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.